Get the Stockscreener App
2.36
43.03%
0.71
Matinas Biopharma Holdings Inc stock is traded at $2.36, with a volume of 22.49M.
It is up +43.03% in the last 24 hours and up +138.29% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.65
Open:
$1.59
24h Volume:
22.49M
Relative Volume:
38.14
Market Cap:
$12.01M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.4927
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
+108.85%
1M Performance:
+138.29%
6M Performance:
+287.33%
1Y Performance:
+1,442%
1-Day Range:
$1.59
$3.09
1-Week Range:
$1.02
$3.09
52-Week Range:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
2.36 | 8.39M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Exit strategy if you’re trapped in Matinas BioPharma Holdings Inc.Trade Performance Summary & Growth Focused Stock Pick Reports - Newser
Can technical indicators confirm Matinas BioPharma Holdings Inc.’s reversalPortfolio Gains Report & Daily Stock Trend Reports - Newser
Matinas BioPharma Holdings Inc. recovery potential after sell offBond Market & Short-Term Trading Opportunity Alerts - Newser
Key resistance and support levels for Matinas BioPharma Holdings Inc.July 2025 Selloffs & Smart Swing Trading Techniques - Newser
Matinas Biopharma (MTNB) Soars 59.39% on Explosive Intraday Surge—What’s Fueling the Momentum? - AInvest
Is Matinas BioPharma Holdings Inc. reversing from oversold territoryWeekly Stock Analysis & Technical Pattern Based Signals - Newser
How to track smart money flows in Cocrystal Pharma Inc.2025 Sector Review & Community Shared Stock Ideas - Newser
What is the target price for Matinas BioPharma Holdings Inc. stockWeekly Investment Summary & Smart Money Movement Tracker - newsimpact.co.kr
Risk vs reward if holding onto Energizer Holdings Inc.2025 Geopolitical Influence & Advanced Technical Analysis Signals - Newser
Can swing trading help recover from Pearl Holdings Acquisition Corp Equity Warrant lossesM&A Rumor & Daily Stock Trend Reports - Newser
What analysts say about FUND stock outlook2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Matinas BioPharma Holdings Inc. Shows Early Signs of Technical Strength [2025 Risk Factors]Accurate Entry/Exit Alerts - sundaytimes.kr
Will breakout in Matinas BioPharma Holdings Inc. lead to full recoveryQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - Newser
Should you wait for a breakout in COSCIENS Biopharma Inc.CEO Change & Low Risk High Win Rate Picks - Newser
How to interpret RSI for SMMT stock2025 Momentum Check & Daily Price Action Insights - Newser
How to build a dashboard for O Reilly Automotive Inc. stockWatch List & Weekly Momentum Picks - Newser
Has Matinas BioPharma Holdings Inc. found a price floorPortfolio Risk Summary & Short-Term Swing Trade Alerts - Newser
What candlestick patterns are forming on Matinas BioPharma Holdings Inc.Value Holding Return Summary With Outlook - Newser
Matinas Biopharma Holdings Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Can Matinas BioPharma Holdings Inc. reach all time highs this yearMulti-Fold Return Candidates - newsyoung.net
Price Channel Expanding on Matinas BioPharma Holdings Inc.’s ChartROI Boosting Trade Opportunity Calendar Published - beatles.ru
Will Matinas BioPharma Holdings Inc. bounce back from current supportEarnings Report Summary with Market Impact - Newser
Published on: 2025-08-11 01:10:21 - Newser
Detecting price anomalies in Bank of the James Financial Group Inc. with AIFree Weekly Top Gainers Forecast Watchlist - Newser
Can volume confirm reversal in Matinas BioPharma Holdings Inc.Equity Forecast with Predictive AI Screener - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.Market Opportunity Tracker for Swing Traders - Newser
When is the best time to buy Toppoint Holdings Inc. stock3-Year Equity Summary With Setup Insights - Newser
Matinas BioPharma Doubles Authorized Common Shares To 500M Following Shareholder Approval - 富途牛牛
What institutional flow reveals about Matinas BioPharma Holdings Inc.Low Drawdown Picks with Weekly Updates - Newser
How to read the order book for Matinas BioPharma Holdings Inc.Market Sentiment Tracker with Smart Alerts - Newser
How to build a custom watchlist for GT Biopharma Inc.Deep Learning Stock Forecast for Investors - Newser
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
How many analysts rate Matinas BioPharma Holdings Inc. as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
What makes Matinas BioPharma Holdings Inc. stock price move sharplyFree Real-Time Market Sentiment Tracking Tool - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Weekly Hot Picks With Buy Confidence - Newser
Should I hold or sell Matinas BioPharma Holdings Inc. stock in 2025Achieve exceptional returns with expert guidance - Jammu Links News
How strong is Matinas BioPharma Holdings Inc. company’s balance sheetMaximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Matinas BioPharma Holdings Inc. stockFree Expert Stock Watchlist - Jammu Links News
When is Matinas BioPharma Holdings Inc. stock expected to show significant growthUnlock exclusive trading strategies - Jammu Links News
How does Matinas BioPharma Holdings Inc. compare to its industry peersStrongest growth potential - Jammu Links News
How does Matinas BioPharma Holdings Inc. generate profit in a changing economySuperior investment outcomes - Jammu Links News
Is Matinas BioPharma Holdings Inc. stock overvalued or undervaluedFree Investment Timing Strategies - Jammu Links News
What is the dividend policy of Matinas BioPharma Holdings Inc. stockHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Matinas BioPharma Holdings Inc. in the next 12 monthsIdentify undervalued stocks poised to rally - jammulinksnews.com
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):